FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/09/045641 [Registered on: 19/09/2022] Trial Registered Prospectively
Last Modified On: 22/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A comparative clinical study on Jatamansi Choorna and Arka in treatment of Anidra (Primary Insomnia) 
Scientific Title of Study   A comparative clinical study on Jatamansi (Nardostachys jatamansi DC.) Choorna and Arka in Anidra (Primary Insomnia) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sarveshwar Saurabh 
Designation  PG Scholar, Department of Manovigyan avum Manasa Roga 
Affiliation  Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan 
Address  Department of Manovigyan avum Manasa Roga Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan

Hassan
KARNATAKA
573201
India 
Phone  9931636081  
Fax    
Email  dr.sarveshwar101@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Savitha HP 
Designation  Professor and Head- Dept of Manovigyan Avum Manasa Roga 
Affiliation  Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan 
Address  Department of Manovigyan avum Manasa Roga Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan

Hassan
KARNATAKA
573201
India 
Phone  9980168208  
Fax    
Email  savithem@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Savitha HP 
Designation  Professor and Head- Dept of Manovigyan Avum Manasa Roga 
Affiliation  Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan 
Address  Department of Manovigyan avum Manasa Roga Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan

Hassan
KARNATAKA
573201
India 
Phone  9980168208  
Fax    
Email  savithem@gmail.com  
 
Source of Monetary or Material Support  
Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan 
 
Primary Sponsor  
Name  Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital Hassan 
Address  Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital BM Road Thanniruhalla Hassan- 573201 Karnataka India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sarveshwar Saurabh  Sri Dharmasthala Manjunatheshwara College of Ayurveda And Hospital Hassan  Department of Manovigyan Avum Manasaroga OPD NO 8 Sri Dharmasthala Manjunatheshwara College of Ayurveda And Hospital, BM Road, Thanniruhalla, Hassan
Hassan
KARNATAKA 
9931636081

dr.sarveshwar101@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Sri Dharmasthala Manjunatheswara College of Ayurveda and Hospital BM Road Hassan 573201 Karnataka India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F510||Insomnia not due to a substance orknown physiological condition. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Jatamansi Churna, Reference: Ayurvedic Formulary of India, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: hs, Bhaishajya Kal: Pragbhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: -Milk), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Jatamansi Arka, Reference: Ayurvedic Formulary of India, Route: Oral, Dosage Form: Arka, Dose: 10(ml), Frequency: hs, Bhaishajya Kal: Pragbhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: -Water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Diagnosed case of primary insomnia
2. Age group between 18-60 years.
3. Subjects of either of the gender, irrespective of socio-economic status.
4. Subjects who are ready to take part in the study with their consent. 
 
ExclusionCriteria 
Details  1. Use of any substance with psychotropic effects or properties knows to affect sleep wake cycle.
2. Subjects with secondary causes like breathing related sleep disorder, psychiatric related sleep disorder, sleep walking disorder.
3. Clinically significant, severe or unstable, acute or chronically progressive medical or surgical disorder.
4. Night shift workers and individuals who nap three or more times per week over the preceding month.
5. Females who are lactating or who are pregnant. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The quantity and quality of sleep will be
assessed by adopting Insomnia Severity Index
scale
 
Before treatment on the 0 day and after treatment on 29th day
 
 
Secondary Outcome  
Outcome  TimePoints 
The quantity and quality of sleep will be
assessed by adopting Insomnia Severity Index
scale
 
On the 14th day of starting medicine and 15 days after completion of medicine
 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "47"
Final Enrollment numbers achieved (India)="47" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/09/2022 
Date of Study Completion (India) 31/07/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title of the Synopsis: A Comparative clinical study on Jatamansi (Nardostachys jatamansi DC.) Choorna and Arka in Anidra (Primary Insomnia)

Summary: 

NEED FOR THE STUDY:

Nidra is one of the trya-upa-stambha mentioned in Ayurveda along with Ahara and Brahmacharya. It is one of the pillars that holds healthy life. Nidra is one of the factors that provides complete relaxation to the mind and body thereby restoring the energy and potential of the body. It provides the body with time and environment to relax, heal itself from fatigue, exhaustion and repair cell damages. So sound sleep is an important part of a healthy life.

But in the modern era, there is great alteration in quantity and quality of sleep due to busy lifestyle, improper ahara and vihara, poor sleeping hygiene, work overload, anxiety and stress arising from day to day activities along with some chronic diseases and medications. This is highly affecting the quality of life of people leading to poor performance in all aspects of life. The consequences of insomnia are significant, such as depression, impaired work performance, work related / motor accidents, poor performance in career, education. Research findings suggest that sleep can increase the risk of developing obesity, diabetes, hypertension and heart disease.

 Insomnia is one of the most common but neglected condition. Various studies worldwide have shown the prevalence of insomnia in 10-30 % of the world population, some even as high as 50-60% of the population.3 Similarly a survey conducted by WHO in India reveals that 35% of the respondents have reported mild to severe trouble with sleep.4 This trend is increasing in the Covid-19 and lockdown situation. There is a high google search trend on insomnia during the recent covid-19 situation.5 Thus insomnia is obviously an important health problem that needs to be addressed.

 Jatamansi (Nardostachys jatamamsi DC), an aromatic herb of the Valerinaceae family possesses Tridosha and Raktadosha hara properties. Jatamamsi choorna is selected as standard control drug for Anidra because it has bhootaghna, nidrakara, medhya, balya, deepana-pachana, hrudya actions and thus is expected to have a comprehensive action over the samprapti vighatana of anidra. Moreover phytochemical and  pharmacological studies have shown several actions like sedative, anxiolytic, antioxidant, antiepileptic, neuroprotective, antidepressant, antifungal, antimicrobial, antioxidant, hepatoprotective, cardio protective actions. The study drug is taken its Arka form because Arka kalpanas are more potent, having a longer shelf life, fast action, palatable and required in smaller doses. The arka kalpana of Jatamamsi will help to preserve all its volatile active principles. This makes it more beneficial, palatable and user-friendly. Thus Jatamansi Arka is expected to provide better result for the management of Anidra.

 

OBJECTIVES OF THE STUDY

·         To evaluate the effectiveness of Jatamansi Arka in Anidra (Primary Insomnia)

·         To evaluate the effectiveness of Jatamansi Choorna in Anidra (Primary Insomnia)

·         To compare the effect of Jatamansi Arka and Jatamansi Choorna in Anidra (Primary insomnia)

 

STUDY DESIGN:

❖                  Type of study: Open label double arm prospective clinical study

❖                  Sampling method: Convenience sampling

❖                  Test: Pretest and Post test

❖                  Sample size: 40 subjects

❖                  Treatment duration: 28 days

 

SOURCE OF DATA:

Patients of Anidra (primary insomnia) will be recruited from in and out patient departments of Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, Karnataka.

 

INCLUSION CRITERIA:

v  Diagnosed case of primary insomnia

v  Age group between 18-60 years.

v  Subjects of either of the gender, irrespective of socio-economic status.

v  Subjects who are ready to take part in the study with their consent.

 

EXCLUSION CRITERIA:

●       Use of any substance with psychotropic effects or properties knows to affect sleep wake cycle.

●       Subjects with secondary causes like breathing related sleep disorder, psychiatric related sleep disorder, sleep walking disorder.

●       Clinically significant, severe or unstable, acute or chronically progressive medical or surgical disorder.

●       Night shift workers and individuals who nap three or more times per week over the preceding month.

●       Females who are lactating or who are pregnant.

 

DIAGNOSTIC CRITERIA:

·         a detailed medical history will be taken and physical examination will be done from both Ayurvedic and modern point of view

·         Mental Status Examination (MSE) will be carried out to assess the mental health condition of the patient

·         routine hematological test will be done to confirm or rule out any other health issues

 

The guidelines mentioned in ICD-10 will be followed

 

v  A complaint of difficulty falling asleep, maintaining sleep, or non-refreshing sleep.

v  The sleep disturbance occurs at least three times per week for at least one month.

v  The sleep disturbance results in marked personal distress or interference with personal functioning in daily living.

v  Absence of any known causative organic factor, such as neurological or other medical condition, psychoactive substance use disorder or a medication

 

ASSESSMENT CRITERIA-

The quantity and quality of sleep will be assessed by using Insomnia Severity Index.

❖                  0–7   = No clinically significant insomnia

❖                  8–14 = Sub threshold insomnia

❖                  15–21 = Clinical insomnia (moderate severity)

❖                  22–28 = Clinical insomnia (severe)

 

ASSESSMENT OF SUBJECT- will be done before treatment and after treatment again


 
Close